Int J Impot Res. 2009;21:68-73

Patients who receive alfuzosin as treatment for benign prostatic hyperplasia (BPH) experience improvements in sexual function as well lower urinary tract symptoms (LUTS), a South Korean study suggests.

In a study of 148 BPH patients with LUTS treated with alfuzosin 10 mg once daily for 24 weeks, investigators evaluated sexual function using the Male Sexual Health Questionnaire (MSHQ) and the International Index of Erectile Function (IIEF).

Continue Reading

At study end point (week 24), subjects showed significant improvement in total MSHQ score and MSHQ ejaculatory scores compared with baseline, as well as significant improvement in IIEF score.